Delivery Order SPE2DB22D3016-SPE2DB25FACA2

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The contract, valued at $5,152.35, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is June 7, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $4,973.90, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is October 28, 2024. This award is not associated with a set-aside designation,...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $2,714.96, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 26, 2023. The award is not designated as a set-aside contract. Amerisourcebergen holds...
The federal contract award is for the delivery of Lidocaine 5% Patches, with a contract value of $8,341.71 and a completion date of June 4, 2024. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Lidocaine 5% patches, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,903.60 firm-fixed price delivery order has a completion date of November 15, 2024 and does not utilize any set-aside requirements, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The prime contractor is AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $6,657.94 and an ultimate completion date of October 21, 2024. The contract is not set aside for any special designation. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 17, 2022. The contract is a Delivery Order with a Firm Fixed Price of $3,576.66 and a period of performance through November 18, 2022. The contract does not have a set-aside designation, indicating it was open competition....
This federal contract award is for the delivery of Lidocaine 5% Patches, worth $2,843.34, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 6, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery...
This contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,976.76 and is a Firm Fixed Price Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 11, 2024. This award is not associated with any set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
This contract award is for the supply of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2024, with a ceiling value of $1,334.51 and an ultimate completion date of May 21, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FACA2
    Delivery Order

This contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA). The $4,394.60 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 1:52 PM